These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14969784)

  • 1. Olanzapine use in a patient with schizophrenia and the risk of diabetes.
    Folnegović-Smalc V; Jukić V; Kozumplik O; Mimica N; Uzun S
    Eur Psychiatry; 2004 Feb; 19(1):62-4. PubMed ID: 14969784
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential for detection bias in the association between olanzapine and diabetes.
    Compton MT; Hill HA
    J Clin Psychiatry; 2004 Feb; 65(2):274; author reply 275. PubMed ID: 15003085
    [No Abstract]   [Full Text] [Related]  

  • 3. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
    Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What evidence is there to show which antipsychotics are more diabetogenic than others?
    Jesus C; Jesus I; Agius M
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S423-8. PubMed ID: 26417808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.
    Yasui-Furukori N; Sato Y; Furukori H; Saito M; Nakagami T; Kaneko S
    J Clin Psychiatry; 2009 Jan; 70(1):95-100. PubMed ID: 19026267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
    Wu PL; Lane HY; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of preexisting diabetes with olanzapine.
    Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
    J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes mellitus during olanzapine and quetiapine treatment in Japan.
    Cohen D
    J Clin Psychiatry; 2005 Feb; 66(2):265-6; author reply 266-7. PubMed ID: 15705015
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient treated with olanzapine developing diabetes de novo: proposal for hyperglycaemia screening.
    Duiverman ML; Cohen D; van Oven W; Nieboer P
    Neth J Med; 2007 Oct; 65(9):346-8. PubMed ID: 17954954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual suspect for antipsychotic-induced diabetes.
    O'Neill MF
    Drug Discov Today; 2005 Oct; 10(20):1338. PubMed ID: 16253867
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
    Peuskens J; De Hert M; Mortimer A;
    Int Clin Psychopharmacol; 2007 May; 22(3):145-52. PubMed ID: 17414740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Olanzapine].
    Wittköpper K; El-Armouche A; Eschenhagen T
    Dtsch Med Wochenschr; 2008 Sep; 133(39):1958-62. PubMed ID: 18798132
    [No Abstract]   [Full Text] [Related]  

  • 14. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
    van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
    J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes as a complication in treatment with second-generation antipsychotics].
    Povlsen UJ; Breum L; Lublin HK
    Ugeskr Laeger; 2004 Aug; 166(35):2977-9. PubMed ID: 15387005
    [No Abstract]   [Full Text] [Related]  

  • 16. Considerations regarding the use of metformin with olanzapine.
    Alamiri B
    Am J Psychiatry; 2008 Sep; 165(9):1205-6; author reply 1207. PubMed ID: 18765498
    [No Abstract]   [Full Text] [Related]  

  • 17. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.
    Ramaswamy K; Masand PS; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(3):183-94. PubMed ID: 16923657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
    Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
    Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine-associated type 2 diabetes mellitus.
    Opp D; Hildebrandt C
    Schizophr Res; 2002 Jul; 56(1-2):195-6. PubMed ID: 12084434
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine: a critical review of recent literature.
    Buckley PF
    Expert Opin Pharmacother; 2005 Oct; 6(12):2077-89. PubMed ID: 16197360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.